BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15196582)

  • 1. Prediction of drug-membrane interactions by IAM-HPLC: effects of different phospholipid stationary phases on the partition of bases.
    Barbato F; di Martino G; Grumetto L; La Rotonda MI
    Eur J Pharm Sci; 2004 Jul; 22(4):261-9. PubMed ID: 15196582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can protonated beta-blockers interact with biomembranes stronger than neutral isolipophilic compounds? A chromatographic study on three different phospholipid stationary phases (IAM-HPLC).
    Barbato F; di Martino G; Grumetto L; La Rotonda MI
    Eur J Pharm Sci; 2005; 25(4-5):379-86. PubMed ID: 15979535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
    Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
    Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipophilic and electrostatic forces encoded in IAM-HPLC indexes of basic drugs: their role in membrane partition and their relationships with BBB passage data.
    Grumetto L; Carpentiero C; Barbato F
    Eur J Pharm Sci; 2012 Apr; 45(5):685-92. PubMed ID: 22306648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary electrochromatography as a new tool to assess drug affinity for membrane phospholipids.
    Barbato F; Grumetto L; Carpentiero C; Rocco A; Fanali S
    J Pharm Biomed Anal; 2011 Apr; 54(5):893-9. PubMed ID: 21168987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data.
    Grumetto L; Carpentiero C; Di Vaio P; Frecentese F; Barbato F
    J Pharm Biomed Anal; 2013 Mar; 75():165-72. PubMed ID: 23261809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
    Kotecha J; Shah S; Rathod I; Subbaiah G
    Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatographic estimation of drug disposition properties by means of immobilized artificial membranes (IAM) and C18 columns.
    Lázaro E; Ràfols C; Abraham MH; Rosés M
    J Med Chem; 2006 Aug; 49(16):4861-70. PubMed ID: 16884298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different retention behavior of structurally diverse basic and neutral drugs in immobilized artificial membrane and reversed-phase high performance liquid chromatography: comparison with octanol-water partitioning.
    Vrakas D; Giaginis C; Tsantili-Kakoulidou A
    J Chromatogr A; 2006 May; 1116(1-2):158-64. PubMed ID: 16595136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrostatic interactions and ionization effect in immobilized artificial membrane retention. A comparative study with octanol-water partitioning.
    Vrakas D; Giaginis C; Tsantili-Kakoulidou A
    J Chromatogr A; 2008 Apr; 1187(1-2):67-78. PubMed ID: 18291408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
    Caldwell GW; Masucci JA; Evangelisto M; White R
    J Chromatogr A; 1998 Mar; 800(2):161-9. PubMed ID: 9561760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction and mechanism elucidation of analyte retention on phospholipid stationary phases (IAM-HPLC) by in silico calculated physico-chemical descriptors.
    Russo G; Grumetto L; Barbato F; Vistoli G; Pedretti A
    Eur J Pharm Sci; 2017 Mar; 99():173-184. PubMed ID: 27919703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is phospholipid-saturated alkyl column a convenient replacement for immobilized-artificial-membrane?
    Luo HB; Zheng C; Cheng YK
    J Chromatogr A; 2007 Dec; 1176(1-2):100-6. PubMed ID: 18022632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative structure-retention relationship studies using immobilized artificial membrane chromatography I: amended linear solvation energy relationships with the introduction of a molecular electronic factor.
    Li J; Sun J; Cui S; He Z
    J Chromatogr A; 2006 Nov; 1132(1-2):174-82. PubMed ID: 16919656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immobilized Artificial Membrane HPLC Derived Parameters vs PAMPA-BBB Data in Estimating in Situ Measured Blood-Brain Barrier Permeation of Drugs.
    Grumetto L; Russo G; Barbato F
    Mol Pharm; 2016 Aug; 13(8):2808-16. PubMed ID: 27377191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indexes of polar interactions between ionizable drugs and membrane phospholipids measured by IAM-HPLC: their relationships with data of Blood-Brain Barrier passage.
    Grumetto L; Russo G; Barbato F
    Eur J Pharm Sci; 2014 Dec; 65():139-46. PubMed ID: 25262853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between human intestinal absorption and polar interactions drug/phospholipids estimated by IAM-HPLC.
    Grumetto L; Russo G; Barbato F
    Int J Pharm; 2015 Jul; 489(1-2):186-94. PubMed ID: 25917756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure-retention relationship studies with immobilized artificial membrane chromatography II: partial least squares regression.
    Li J; Sun J; He Z
    J Chromatogr A; 2007 Jan; 1140(1-2):174-9. PubMed ID: 17161410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting drug-membrane interactions by HPLC: structural requirements of chromatographic surfaces.
    Liu H; Ong S; Glunz L; Pidgeon C
    Anal Chem; 1995 Oct; 67(19):3550-7. PubMed ID: 8686902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of drug absorption based on immobilized artificial membrane (IAM) chromatography separation and calculated molecular descriptors.
    Yen TE; Agatonovic-Kustrin S; Evans AM; Nation RL; Ryand J
    J Pharm Biomed Anal; 2005 Jul; 38(3):472-8. PubMed ID: 15890485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.